Rep. Gus M. Bilirakis

Maddy summaryHRES 166 is a non-binding House resolution expressing U.S. support for the Iranian people's desire for a democratic, secular, and nonnuclear republic. It condemns the Iranian regime's terrorism, regional proxy wars, internal suppression of ethnic and religious minorities, and human rights abuses - including executions and repression of women-led protests. The resolution calls for holding the regime accountable through sanctions, supports the Ten-Point Plan for Iran’s democratic transition, and urges protection for Iranian political refugees in Albania. It does not create new laws but affirms U.S. policy alignment with Iranian protesters' demands.

Maddy summaryThis bill awards a Congressional Gold Medal to the 761st Tank Battalion (known as the "Black Panthers"), the first predominantly Black armored unit in World War II's European Theater. It recognizes their combat service from 1944-1946, including key roles in the Battle of the Bulge and breaking the Siegfried Line, despite facing racial prejudice during and after the war. The medal will be displayed at the National Museum of African American History and Culture, with bronze duplicates available for sale to cover costs. The bill commemorates the battalion's 130,000 enemy casualties inflicted, 50% casualty rate, and their 1978 Presidential Unit Citation. It does not create new laws or affect current policies.

Maddy summaryThis bill expands Medicare, Medicaid, and CHIP coverage for specific cancer diagnostic tests, directly affecting cancer patients enrolled in these programs. It requires Medicare to cover genetic tests like DNA sequencing (80% of cost) and limits testing frequency to once at diagnosis, once for recurrence, and as needed for treatment planning. Medicaid and CHIP must include these tests as mandatory coverage starting January 1, 2027, with states given flexibility to comply via state legislation. The bill also mandates a new HHS education program to inform doctors and the public about genomic testing for cancer care.

Maddy summaryHouse Resolution 152 is a symbolic congressional resolution reaffirming the U.S.-Canada partnership. It highlights their $1 trillion annual trade relationship (supporting 8 million U.S. jobs), joint border security efforts against fentanyl trafficking, and energy cooperation - including Canada as the U.S.'s top oil supplier and critical minerals partner. The resolution emphasizes shared security interests, integrated supply chains, and collaboration on defense, Arctic security, and democratic values. It does not create new laws but formally expresses congressional support for strengthening this alliance.

New Era of Preventing End-Stage Kidney Disease Act This bill establishes regional centers of excellence, postgraduate fellowships, and training for health professionals relating to the diagnosis and treatment of rare kidney disease. It also requires the Department of Health and Human Services (HHS) to conduct various studies on rare kidney disease. Specifically, it authorizes the National Institute of Diabetes and Digestive and Kidney Diseases to award funding to public and private nonprofit entities for establishing regional centers of excellence that will increase public awareness, conduct research, and develop resources for diagnosing and treating rare kidney diseases. A center may receive such funding for up to five years, unless extended by the institute.  The bill also requires health professions schools receiving a grant from the Health Resources and Services Administration (HRSA) Centers of Excellence program to award fellowships for training on preventing, diagnosing, and treating rare kidney disease in disproportionately impacted populations. Also, the bill expands the priorities of HRSA’s Primary Care Training and Enhancement program to include training for health care workers to care for individuals with kidney disease. Additionally, HHS must conduct several studies and report to Congress on topics such as treating rare kidney disease in disproportionately affected populations, eliminating the need for dialysis or kidney transplants, and increasing public awareness of rare kidney disease.

Maddy summaryThis bill allows physical therapists to use temporary replacement staff (locum tenens) under Medicare, similar to how physicians currently can. It directly affects physical therapists providing outpatient services and Medicare beneficiaries relying on those services. The key change modifies Medicare rules to apply the same provisions for physical therapy services as are already used for physician services. This means physical therapists can more easily fill temporary staffing gaps without disrupting patient care. The amendment applies to services provided after the bill's enactment date.

Promoting Responsible and Effective Virtual Experiences through Novel Technology to Deliver Improved Access and Better Engagement with Tested and Evidence-based Strategies Act or the PREVENT DIABETES Act This bill allows health care entities to provide virtual services under the Medicare Diabetes Prevention Program for an additional three years. The Medicare Diabetes Prevention Program offers Medicare beneficiaries who are at risk of developing Type 2 diabetes specialized training and education regarding diet, exercise, and other behavioral changes. The Centers for Medicare & Medicaid Services issued temporary authorization for entities participating in the program to provide these services virtually until December 31, 2027. The bill extends the authorization for virtual services until December 31, 2030.

Maddy summaryHR 1539, the Medical Device Electronic Labeling Act, allows medical device manufacturers to provide required product labeling exclusively through electronic means, rather than physical copies. This change directly affects device manufacturers, healthcare providers, and patients who access device information. Key provisions require that electronic labeling be readily accessible online, manufacturers must provide paper copies upon request without cost, and the physical device label must still include essential safety and usage information. The bill does not alter existing safety standards but updates how labeling is delivered, with the FDA retaining authority to issue additional requirements via Federal Register notices for specific devices.

Maddy summaryHR 1532, the Scientific EXPERT Act of 2025, creates a new process for FDA to host annual "science-focused drug development meetings" (EL-SFDD meetings) specifically for rare diseases. The bill requires the Reagan-Udall Foundation to convene at least four such meetings yearly, bringing together FDA staff, drug developers, medical experts, patient groups, and scientific organizations to discuss scientific challenges and align on approaches like clinical trial designs and endpoints. The FDA must publicly summarize meeting outcomes and explain how input influenced drug approvals, while also reporting annually on meeting impact. This directly affects rare disease drug developers, FDA review divisions, and patient advocacy groups participating in these structured scientific discussions. The bill does not change drug approval standards but aims to streamline development through better scientific alignment.

Maddy summaryHR 1502 authorizes the creation of a Congressional Gold Medal to honor the volunteers and communities (primarily from Nebraska, Colorado, and Kansas) who supported the North Platte Canteen during World War II. The bill directs the Treasury Secretary to design and strike the medal, which will be presented to the individuals who contributed to the canteen’s operations and then permanently displayed at the Lincoln County Historical Museum in North Platte, Nebraska. It also permits the sale of bronze duplicates to cover production costs, with proceeds going to the U.S. Mint. This is a commemorative measure recognizing historical service, not a policy change affecting current laws or programs.